Literature DB >> 3768722

Behavioral effects of a single neuroleptic treatment grow with the passage of time.

S M Antelman, D Kocan, D J Edwards, S Knopf, J M Perel, R Stiller.   

Abstract

The principal finding of this manuscript is that the incidence of catalepsy observed in the rat after a single administration of low, clinically relevant doses of the dopamine receptor antagonists and antipsychotic agents, haloperidol and fluphenazine hydrochloride, grows over time such that one re-exposure to the same compound up to 8 weeks later results in a marked enhancement (i.e. sensitization) of this response. This phenomenon appears to be independent of pharmacokinetic or conditioning factors as well as alterations in dopamine or dihydroxyphenylacetic acid. It suggests that the antidopaminergic influence of acute exposure to a neuroleptic not only persists but continues to sensitize for extraordinary periods of time even after the drug is no longer detectable in the system. Our findings may hold the key to understanding the apparent paradox that although neuroleptics presumably induce their therapeutic actions in disorders such as Tourette syndrome and schizophrenia as well as their parkinsonian effects by blocking dopamine receptors, this antagonism occurs immediately while behavioral changes often require weeks for maximal development.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768722     DOI: 10.1016/0006-8993(86)91547-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model.

Authors:  Qing Shu; Gang Hu; Ming Li
Journal:  J Psychopharmacol       Date:  2013-11-20       Impact factor: 4.153

2.  Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.

Authors:  J G Csernansky; E P Bellows; D E Barnes; L Lombrozo
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Sensitization to haloperidol-induced suppression of milk intake: effect of interdose interval.

Authors:  D L Wolgin; J Moore
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stressful/foreign nature of drugs.

Authors:  S M Antelman; A R Caggiula; S Knopf; D J Kocan; D J Edwards
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.

Authors:  B M Cohen; T Tsuneizumi; R J Baldessarini; A Campbell; S M Babb
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Persistent sensitization of clonidine-induced hypokinesia following one exposure to a stressor: possible relevance to panic disorder and its treatment.

Authors:  S M Antelman; S Knopf; D Kocan; D J Edwards
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.

Authors:  Jun Gao; Ming Li
Journal:  Behav Brain Res       Date:  2013-10-05       Impact factor: 3.332

8.  Haloperidol prevents ethanol-stimulated locomotor activity but fails to block sensitization.

Authors:  J Broadbent; N J Grahame; C L Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

9.  A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal.

Authors:  Thomas V Wiecki; Katrin Riedinger; Andreas von Ameln-Mayerhofer; Werner J Schmidt; Michael J Frank
Journal:  Psychopharmacology (Berl)       Date:  2009-01-24       Impact factor: 4.530

10.  Effects of chronic haloperidol treatment on amygdaloid seizure generation in cats.

Authors:  Y Minabe; M Tsutsumi; M Kurachi
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.